Chatchada Karanes

7.7k total citations · 1 hit paper
148 papers, 4.5k citations indexed

About

Chatchada Karanes is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, Chatchada Karanes has authored 148 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Hematology, 50 papers in Oncology and 41 papers in Genetics. Recurrent topics in Chatchada Karanes's work include Hematopoietic Stem Cell Transplantation (71 papers), Multiple Myeloma Research and Treatments (39 papers) and Acute Myeloid Leukemia Research (39 papers). Chatchada Karanes is often cited by papers focused on Hematopoietic Stem Cell Transplantation (71 papers), Multiple Myeloma Research and Treatments (39 papers) and Acute Myeloid Leukemia Research (39 papers). Chatchada Karanes collaborates with scholars based in United States, Taiwan and Singapore. Chatchada Karanes's co-authors include Frederick R. Appelbaum, Voravit Ratanatharathorn, Eric L. Sievers, Joseph P. Uberti, Jacques J. M. van Dongen, Richard A. Larson, Elihu H. Estey, Esteban Abella, Mary Eapen and Claudio G. Brunstein and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Chatchada Karanes

144 papers receiving 4.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse

2001 654 citations Chatchada Karanes et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Chatchada Karanes

Since Specialization

Citations

This map shows the geographic impact of Chatchada Karanes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chatchada Karanes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chatchada Karanes more than expected).

Fields of papers citing papers by Chatchada Karanes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chatchada Karanes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chatchada Karanes. The network helps show where Chatchada Karanes may publish in the future.

Co-authorship network of co-authors of Chatchada Karanes

This figure shows the co-authorship network connecting the top 25 collaborators of Chatchada Karanes. A scholar is included among the top collaborators of Chatchada Karanes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chatchada Karanes. Chatchada Karanes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Crenolanib and Intensive Chemotherapy in Adults With Newly Diagnosed FLT3-Mutated AML 2024 ·Journal of Clinical Oncology ·Eunice S. Wang, Aaron D. Goldberg, Martin S. Tallman, Roland B. Walter, Chatchada Karanes, Karamjeet Sandhu, Carlos E. Vigil, Robert H. Collins, Vinay Jain, Richard M. Stone	22
2	Posttransplant cyclophosphamide as GVHD prophylaxis for peripheral blood stem cell HLA-mismatched unrelated donor transplant 2021 ·Blood Advances ·Monzr M. Al Malki, Ni‐Chun Tsai, Joycelynne Palmer, Sally Mokhtari, Weimin Tsai, Thai M. Cao, Haris Ali, Amandeep Salhotra, Shukaib Arslan, Ibrahim Aldoss, Nicole Karras, Chatchada Karanes, Jasmine M. Zain, Samer K. Khaled, Anthony S. Stein, David S. Snyder, Guido Marcucci, Stephen J. Forman, Ryotaro Nakamura	32
3	Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial 2020 ·Blood ·Ephraim J. Fuchs, Paul V. O’Donnell, Mary Eapen, Brent R. Logan, Joseph H. Antin, Peter Dawson, Steven M. Devine, Mary M. Horowitz, Mitchell E. Horwitz, Chatchada Karanes, Eric Leifer, John Magenau, Joseph P. McGuirk, Lawrence E. Morris, Andrew R. Rezvani, Richard J. Jones, Claudio G. Brunstein	106
4	Iron Overload Is Associated with Delayed Engraftment and Increased Nonrelapse Mortality in Recipients of Umbilical Cord Blood Hematopoietic Cell Transplantation 2020 ·Biology of Blood and Marrow Transplantation ·Monzr M. Al Malki, Joo Y. Song, Dongyun Yang, Thai M. Cao, Ibrahim Aldoss, Sally Mokhtari, Sanjeet Dadwal, Guido Marcucci, Chatchada Karanes, David S. Snyder, Auayporn Nademanee, Stephen J. Forman, Ryotaro Nakamura, Vinod Pullarkat	9
5	Repurposing Leflunomide for Relapsed/Refractory Multiple Myeloma: A Phase 1 Trial 2017 ·Blood ·Michael Rosenzweig, Joycelynne Palmer, Ni‐Chun Tsai, Ralf Buettner, (unknown), Myo Htut, Chatchada Karanes, Nitya Nathwani, Flavia Pichiorri, Firoozeh Sahebi, George Somlo, Timothy W. Synold, Xiwei Wu, Amrita Krishnan, Stephen J. Forman, Steven T. Rosen	0
6	Transfusion- Related Iron Overload (TRIO) Is Associated with Delayed Engraftment and Increased Non Relapse Mortality (NRM) in Patients Undergoing Umbilical Cord Blood (UCB) Hematopoietic Cell Transplantation (HCT) 2017 ·Blood ·Monzr M. Al Malki, Joo Y. Song, Dongyun Yang, Thai M. Cao, Ibrahim Aldoss, Sally Mokhtari, Sanjeet Dadwal, Ketevan Gendzekhadze, Anna Pawłowska, (unknown), Guido Marcucci, Chatchada Karanes, Pablo Parker, David S. Snyder, David Senitzer, Auayporn Nademanee, Stephen J. Forman, Ryotaro Nakamura, Vinod Pullarkat	2
7	Low Relapse Rate in Younger Patients ≤ 60 Years Old with Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia (AML) Treated with Crenolanib and Cytarabine/Anthracycline Chemotherapy 2017 ·Blood ·Eunice S. Wang, Martin S. Tallman, Richard M. Stone, Roland B. Walter, Chatchada Karanes, Vinay Jain, Robert H. Collins	31
8	Initial Phase 2 Results of Ibrutinib Combined with Carfilzomib/Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma 2017 ·Blood ·Ajai Chari, Saulius Girnius, Saurabh Chhabra, Robert F. Cornell, Cristina Gasparetto, Chatchada Karanes, Matthew A. Lunning, Jeffrey Matous, Rubén Niesvizky, Chaim Shustik, Robert K. Stuart, (unknown), (unknown), Zeena Salman, Thorsten Graef, Jason Valent	2
9	Reliability, Validity, and Feasibility of a Computer-Based Geriatric Assessment for Older Adults With Cancer 2016 ·Journal of Oncology Practice ·Arti Hurria, Chie Akiba, Jérôme H. Kim, (unknown), Matthew Loscalzo, Vani Katheria, Marianna Koczywas, Sumanta K. Pal, Vincent Chung, Stephen J. Forman, Nitya Nathwani, Marwan Fakih, Chatchada Karanes, Dean Lim, Leslie Popplewell, Harvey Jay Cohen, Beverly Canin, David Cella, Betty Ferrell, Leanne Goldstein	65
10	Association of Hyperglycemia with Prolonged Hospital Stay But No Effect on Engraftment After Autologous Hematopoietic Stem Cell Transplantation 2012 ·Endocrine Practice ·(unknown), (unknown), (unknown), Chatchada Karanes, Ken C. Chiu	11
11	A phase 1 trial dose-escalation study of tipifarnib on a week-on, week-off schedule in relapsed, refractory or high-risk myeloid leukemia 2011 ·Leukemia ·Mark Kirschbaum, Timothy W. Synold, Anthony S. Stein, Joseph M. Tuscano, Jasmine Zain, Leslie Popplewell, Chatchada Karanes, Margaret O’Donnell, (unknown), Ana Rosa Rincón‐Sánchez, James R. Wright, Paul Frankel, Stephen J. Forman, Edward M. Newman	14
12	Unrelated donor stem cell transplant: donor selection and search process 2003 ·Pediatric Transplantation ·Chatchada Karanes	3
13	Outcome of Relapsed Non-Hodgkin's Lymphoma Patients After Allogeneic and Autologous Transplantation 2002 ·Cancer Investigation ·Ulka N. Vaishampayan, Chatchada Karanes, Wei Du, Mary Varterasian, Ayad Al‐Katib	11
14	High-dose chemotherapy and CD34-selected peripheral blood progenitor cell transplantation for patients with breast cancer metastatic to bone and/or bone marrow 2001 ·Bone Marrow Transplantation ·(unknown), Caroline Hamm, (unknown), Chatchada Karanes, Esteban Abella, (unknown), WP Peters, RD Baynes	4
15	High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Breast Cancer 2000 ·Cancer Investigation ·Roy D. Baynes, Roger Dansey, Jared Klein, Chatchada Karanes, (unknown), Esteban Abella, Wei‐Zen Wei, Anne Galy, Wei Du, Gary S. Wood, William P. Peters	8
16	Cyclophosphamide and paclitaxel as initial or salvage regimen for the mobilization of peripheral blood progenitor cells 1999 ·Bone Marrow Transplantation ·(unknown), (unknown), Roger Dansey, Chatchada Karanes, Esteban Abella, (unknown), Caroline Hamm, Mary E.D. Flowers, (unknown), WP Peters, RD Baynes	10
17	Transplantation in Patients With Multiple Myeloma 1997 ·American Journal of Clinical Oncology ·Mary Varterasian, Nalini Janakiraman, Chatchada Karanes, Esteban Abella, Joseph P. Uberti, (unknown), (unknown), Ayad Al‐Katib, Wei Du, S. Silver, Paul T. Adams, LL Sensenbrenner, Voravit Ratanatharathorn	18
18	Prevention of Hemorrhagic Cystitis Following Allogeneic Bone Marrow Transplant Preparative Regimens With Cyclophosphamide and Busulfan 1995 ·The Journal of Urology ·Levent N. Türkeri, Lawrence G. Lum, Joseph P. Uberti, Esteban Abella, Feroze Momin, Chatchada Karanes, Lyle L. Sensenbrenner, Gabriel P. Haas	1
19	Allogeneic Bone Marrow Transplantation in Patients with Myelodysplastic Syndromes 1994 ·Leukemia & lymphoma ·Joseph P. Uberti, Voravit Ratanatharathorn, Chatchada Karanes, Lyle L. Sensenbrenner	5
20	Lymphomas: MR imaging contrast characteristics with clinical-pathologic correlations. 1990 ·Radiology ·William Negendank, Ayad Al‐Katib, Chatchada Karanes, Mitchell R. Smith	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact